Eye Diseases
At Diakonie Klinikum Dietrich Bonhoeffer GmbH, much of the clinical trial activity focuses on ophthalmology, especially age-related macular degeneration, geographic atrophy, diabetic retinopathy, and macular neovascularization. These studies are exploring new ways to slow vision loss, protect retinal function, and improve visual outcomes for people with progressive eye disease.
- Testing new treatments for diabetic retinopathy to improve retinal health and vision
- Evaluating therapies for geographic atrophy linked to age-related macular degeneration
- Studying approaches for dry AMD and related forms of retinal degeneration
- Assessing options for macular neovascularization to preserve sight
Overall, the site is contributing to research on both symptom control and disease modification in major retinal disorders.
Neoplasms
The cancer research portfolio at this hospital includes trials in rectal cancer, diffuse large B-cell lymphoma, and chronic lymphocytic leukemia/small lymphocytic lymphoma. The main goal is to evaluate whether newer treatment strategies can improve tumor control, support organ preservation, and extend the time patients remain free from disease progression.
- Investigating treatment strategies for intermediate and high-risk rectal cancer with a focus on preserving the rectum
- Testing new combinations for diffuse large B-cell lymphoma to improve response rates
- Studying therapies for relapsed or refractory CLL/SLL to delay progression and improve durability of response
These oncology studies reflect a strong interest in both solid tumors and blood cancers, with an emphasis on better treatment effectiveness and quality of life.
